Q1 2023 Earnings Estimate for Stryker Co. Issued By Oppenheimer (NYSE:SYK)
Q1 2023 Earnings Estimate for Stryker Co. Issued By Oppenheimer (NYSE:SYK)
Stryker Co. (NYSE:SYK – Get Rating) – Oppenheimer issued their Q1 2023 earnings estimates for shares of Stryker in a report released on Wednesday, February 1st. Oppenheimer analyst S. Lichtman expects that the medical technology company will post earnings per share of $2.01 for the quarter. The consensus estimate for Stryker's current full-year earnings is $9.83 per share. Oppenheimer also issued estimates for Stryker's Q2 2023 earnings at $2.46 EPS, Q3 2023 earnings at $2.41 EPS, Q4 2023 earnings at $3.12 EPS and FY2024 earnings at $11.11 EPS.
Stryker Co.(纽约证券交易所代码:SYK-GET Rating)-奥本海默在2月1日星期三发布的一份报告中发布了他们对Stryker股票2023年第一季度收益的预期。奥本海默分析师S·利希特曼预计,这家医疗技术公司本季度的每股收益将达到2.01美元。对Stryker目前全年收益的普遍估计是每股9.83美元。奥本海默还发布了对Stryker 2023年第二季度每股收益2.46美元、2023年第三季度每股收益2.41美元、2023年第四季度每股收益3.12美元和2024财年每股收益11.11美元的预期。
Stryker (NYSE:SYK – Get Rating) last posted its earnings results on Tuesday, January 31st. The medical technology company reported $3.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.84 by $0.16. The business had revenue of $5.20 billion for the quarter, compared to analyst estimates of $4.97 billion. Stryker had a net margin of 12.78% and a return on equity of 22.70%. Stryker's revenue was up 10.7% compared to the same quarter last year. During the same period last year, the business posted $2.71 EPS.
Stryker(纽约证券交易所代码:SYK-GET Rating)最近一次公布收益结果是在1月31日星期二。这家医疗技术公司公布本季度每股收益(EPS)为3.00美元,超出分析师普遍预期的2.84美元,超出0.16美元。该业务本季度营收为52亿美元,而分析师预期为49.7亿美元。Stryker的净利润率为12.78%,股本回报率为22.70%。与去年同期相比,Stryker的收入增长了10.7%。去年同期,该业务公布的每股收益为2.71美元。
Stryker Price Performance
Stryker价格表现
Shares of Stryker stock opened at $282.48 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 2.04. The firm's 50-day simple moving average is $247.78 and its 200-day simple moving average is $226.11. Stryker has a twelve month low of $188.84 and a twelve month high of $282.56. The firm has a market cap of $106.90 billion, a P/E ratio of 45.35, a price-to-earnings-growth ratio of 2.83 and a beta of 0.93.
周四,Stryker的股票开盘报282.48美元。该公司的负债权益比率为0.77,速动比率为1.19,流动比率为2.04。该公司的50日简单移动均线切入位在247.78美元,200日简单移动均线切入位在226.11美元。Stryker的12个月低点为188.84美元,12个月高位为282.56美元。该公司市值为1,069亿美元,市盈率为45.35倍,市盈率为2.83倍,贝塔系数为0.93。
Institutional Investors Weigh In On Stryker
机构投资者看好Stryker
A number of institutional investors and hedge funds have recently bought and sold shares of the company. AMG National Trust Bank increased its position in Stryker by 18.0% during the 3rd quarter. AMG National Trust Bank now owns 18,650 shares of the medical technology company's stock valued at $3,778,000 after buying an additional 2,851 shares in the last quarter. J.W. Cole Advisors Inc. raised its holdings in Stryker by 5.0% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 2,757 shares of the medical technology company's stock worth $558,000 after purchasing an additional 132 shares during the period. Lincoln National Corp raised its holdings in Stryker by 8.0% in the 2nd quarter. Lincoln National Corp now owns 5,668 shares of the medical technology company's stock worth $1,128,000 after purchasing an additional 421 shares during the period. Asset Dedication LLC acquired a new position in shares of Stryker during the third quarter valued at approximately $184,000. Finally, SG Americas Securities LLC raised its holdings in shares of Stryker by 117.7% during the second quarter. SG Americas Securities LLC now owns 18,095 shares of the medical technology company's stock valued at $3,600,000 after acquiring an additional 9,782 shares during the last quarter. 77.10% of the stock is owned by institutional investors.
一些机构投资者和对冲基金最近买卖了该公司的股票。AMG国民信托银行第三季度将其在Stryker的头寸增加了18.0%。AMG国民信托银行现在拥有这家医疗技术公司18,650股股票,价值377.8万美元,上个季度又购买了2,851股。J.W.Cole Advisors Inc.在第三季度将其持有的Stryker股份增加了5.0%。J.W.Cole Advisors Inc.在此期间又购买了132股,现在拥有2,757股这家医疗技术公司的股票,价值55.8万美元。林肯国家公司在第二季度增持了8.0%的Stryker股份。林肯国家公司现在拥有5668股医疗技术公司的股票,价值112.8万美元,在此期间又购买了421股。资产奉献有限责任公司在第三季度收购了Stryker股票的新头寸,价值约为18.4万美元。最后,SG America Securities LLC在第二季度将其持有的Stryker股票增加了117.7%。SG America Securities LLC现在拥有这家医疗技术公司18,095股股票,价值3,600,000美元,上个季度又购买了9,782股。77.10%的股份由机构投资者持有。
Insiders Place Their Bets
内部人士下注
In other news, Director Srikant M. Datar sold 300 shares of the firm's stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $212.36, for a total value of $63,708.00. Following the transaction, the director now owns 4,861 shares of the company's stock, valued at $1,032,281.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Kevin Lobo sold 67,232 shares of Stryker stock in a transaction that occurred on Friday, December 2nd. The stock was sold at an average price of $239.68, for a total value of $16,114,165.76. Following the completion of the transaction, the chief executive officer now owns 80,770 shares in the company, valued at approximately $19,358,953.60. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Srikant M. Datar sold 300 shares of the business's stock in a transaction on Monday, November 7th. The shares were sold at an average price of $212.36, for a total value of $63,708.00. Following the transaction, the director now owns 4,861 shares of the company's stock, valued at approximately $1,032,281.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 79,139 shares of company stock valued at $19,150,115. Insiders own 6.70% of the company's stock.
其他新闻方面,董事Srikant M.Datar在一笔日期为11月7日(星期一)的交易中出售了300股该公司股票。这只股票的平均售价为212.36美元,总价值为63,708.00美元。交易完成后,董事现在持有该公司4861股股票,价值1032,281.96美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过这个环节。在其他新闻方面,首席执行官凯文·洛博在12月2日(星期五)的一笔交易中出售了67,232股Stryker股票。这只股票的平均售价为239.68美元,总价值为16,114,165.76美元。交易完成后,首席执行官现在拥有该公司80,770股,价值约19,358,953.60美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过美国证券交易委员会网站。此外,在11月7日星期一的一次交易中,董事出售了300股该公司的股票。这些股票的平均价格为212.36美元,总价值为63,708.00美元。交易完成后,董事现在持有该公司4861股股票,价值约1032,281.96美元。关于这次销售的披露可以找到这里。在过去的三个月里,内部人士已经出售了79,139股公司股票,价值19,150,115美元。内部人士持有该公司6.70%的股份。
Stryker Increases Dividend
Stryker增加股息
The company also recently announced a quarterly dividend, which was paid on Tuesday, January 31st. Shareholders of record on Friday, December 30th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.06%. This is a boost from Stryker's previous quarterly dividend of $0.70. The ex-dividend date of this dividend was Thursday, December 29th. Stryker's dividend payout ratio (DPR) is presently 48.62%.
该公司最近还宣布了季度股息,股息于1月31日(星期二)支付。12月30日(星期五)登记在册的股东获得了0.75美元的股息。这意味着年化股息为3.00美元,收益率为1.06%。这比Stryker之前0.70美元的季度股息有所提振。本次股息除息日期为12月29日星期四。Stryker的股息支付率(DPR)目前为48.62%。
Stryker Company Profile
Stryker公司简介
(Get Rating)
(获取评级)
Stryker Corp. operates as a medical technology company. It operates through the following segments: Orthopaedics & Spine and MedSurg & Neurotechnology. The Orthopaedics & Spine segment provides implants for use in total joint replacements, such as hip, knee, and shoulder, and trauma and extremities surgeries.
Stryker Corp.是一家医疗技术公司。它通过以下部门开展业务:整形外科和脊柱以及医学外科和神经技术。骨科和脊柱部门提供用于全关节置换的植入物,如髋关节、膝盖和肩部,以及创伤和四肢手术。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Stryker (SYK)
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
- 免费获取StockNews.com关于Stryker的研究报告(SYK)
- 凯西·伍兹的方舟创新ETF将在2023年反弹?
- 马伦汽车公司股票因利好消息而上涨
- 哈雷-戴维森公司的股票,是时候买入了吗?
- Meta平台的底部已经到了,波动性还没有结束
- 阿拉斯加航空公司近期收益分析
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
接受Stryker Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Stryker和相关公司的最新新闻和分析师评级的每日简要摘要。